Seroquel - News Articles

Free Preview - WSJ.com
Jul 29, 2008
Wall Street Journal -
By JEANNE WHALEN Sanofi-Aventis SA said a court in Germany allowed a generic version of the company's blockbuster drug Plavix onto the market there, ...
German court backs immediate generic Plavix | Industries | Health & Drugs | Reuters
Jul 29, 2008
Reuters -
By Ben Hirschler LONDON (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA: Quote, Profile, Research) and its US partner Bristol-Myers Squibb Co (BMY. N) Quote Profile ...
Health Blog : Global Generics Rush: Plavix in Germany, Depakote in U.S.
Jul 30, 2008
Wall Street Journal Blogs, NY -
1. Abbott’s Depakote, approved for epilepsy, bipolar disorder and migraines, is now generic in the US, the FDA said. A bunch of generics manufacturers — including Teva, Dr. Reddy’s and Novartis’s Sandoz — will sell the drug, the agency said. Depakote was ...
Bloomberg.com: U.K. & Ireland
Jul 31, 2008
Bloomberg -
By Trista Kelley July 31 (Bloomberg) -- Sanofi-Aventis SA, France's largest drugmaker, reported second-quarter earnings that missed analyst estimates, ...
Rising sales, weaker dollar boost AstraZeneca's quarterly profit | delawareonline | The News Journal
Friday, August 01, 2008
The News Journal, DE -
The antipsychotic drug Seroquel saw a sales gain of 15 percent in the quarter, and asthma treatment Symbicort rose by 25 percent. Sales of the breast cancer ...
Handa Files ANDA for Generic Seroquel XR - Health - redOrbit
Friday, August 01, 2008
RedOrbit, TX -
Handa Pharmaceuticals has confirmed that its abbreviated new drug application for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR, has been accepted for filing by the FDA. ...
SunHerald.com : Janssen Announces Launch of Authorized Generic for RISPERDAL(R)
Jun 30, 2008
SunHerald.com, MS -
By Johnson & Johnson Patriot is a subsidiary of McNeil-PPC. Both companies are a part of the Johnson & Johnson family of companies. Janssen also announced that it will continue to make available branded RISPERDAL, which was ...
Newsticker - Nachrichten-Newsticker von Welt Online - st?ndig aktuelle Nachrichten und Informationen - WELT ONLINE
Jun 30, 2008
WELT ONLINE, Germany -
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) announced today that the US Food and Drug Administration has granted final approval for the Company's ...
The Canadian Press: Teva receives FDA approval for generic anti-psychotic drug Risperdal
Jun 30, 2008
The Canadian Press, NEW YORK -
NEW YORK — Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd. on Monday became the first company to receive approval for a generic version. Israel-based Teva received U.S. Food and Drug ...
Globes [online] - Israel business news - UBS ups Teva forecast ahead of Risperdal launch
Jun 29, 2008
Globes, Israel -
UBS Securities has raised its earnings per share forecast for Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) on expectations that it will launch generic Risperdal today. UBS analyst Ricky Goldwasser predicts an extra $0.10 earnings per share in 2008, assuming that ...
Teva says FDA grants final approval of generic version of Risperdal
Jun 30, 2008
Trading Markets (press release), CA -
SAN FRANCISCO, Jul 01, 2008 (Thomson Financial via COMTEX) -- TEVA | Quote | Chart | News | PowerRating -- Teva Pharmaceutical Industries Ltd. said Monday ...
FDA Approves First Generic Risperidone to Treat Psychiatric Conditions
Jun 30, 2008
FDA.gov -
The US Food and Drug Administration today approved the first generic versions of Risperdal (risperidone) tablets. Risperdal is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder, and other psychiatric conditions. "This generic drug ...
RTTNews - Breaking News, financial breaking News, Positive EPS Surprises, Stock research ....
Jun 30, 2008
RTT News, NY -
(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA: News, Chart, Quote ) said Monday that it received final approval for the its Abbreviated New Drug Application or ANDA to market its generic version of Janssen's antipsychotic agent Risperdal tablets, 0.25 mg, 0.5 mg, 1 ...
Janssen Announces Launch of Authorized Generic for RISPERDAL(R)
Jun 30, 2008
Earthtimes (press release), UK -
Patriot is a subsidiary of McNeil-PPC. Both companies are a part of the Johnson & Johnson family of companies. Janssen also announced that it will continue to make available branded RISPERDAL, which was first approved by the FDA in 1993. RISPERDAL (risperidone) is indicated ...
FDA: Older psych drugs may be dangerous to seniors suffering from dementia | Wilkes-Barre lifestyle, gardening, home and society news | timesleader.com - The Times Leader
Monday, June 30, 2008
Wilkes Barre Times-Leader, PA -
WASHINGTON — The Food and Drug Administration warned doctors last month that prescribing a certain group of psychiatric drugs to seniors suffering from dementia ...
Teva wins approval for generic Risperdal tablets
Tuesday, July 01, 2008
Trading Markets (press release), CA -
Jul 01, 2008 (Datamonitor via COMTEX) -- TEVA | Quote | Chart | News | PowerRating -- Teva Pharmaceutical Industries has announced that the FDA has granted final approval for the company's abbreviated new drug application to market its generic version of Janssen's antipsychotic agent Risperdal ...
J&J fights Teva with generic Risperdal - FiercePharma
Tuesday, July 01, 2008
FiercePharma, DC -
By Tracy Staton It's a watershed moment: Risperdal has gone generic. The Johnson & Johnson antipsychotic med now has copycat competition from Teva Pharmaceutical, which got the final FDA go-ahead yesterday. As soon as the agency gave its OK, Teva started shipping. ...
Globes [online] - Israel business news - Employees strike half day at Copaxone facility
Tuesday, July 01, 2008
Globes, Israel -
Employees at the troubled Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) subsidiary, Teva Tech, staged a three-hour walkout at the company's ...
FDA OKs generic risperidone - UPI.com
Tuesday, July 01, 2008
United Press International -
WASHINGTON, July 1 (UPI) -- The US Food and Drug Administration says it's approved the first generic versions of Risperdal tablets for certain psychiatric disorders. The FDA said Risperdal (risperidone) is an anti-psychotic drug used for the treatment of schizophrenia, bipolar ...
Teva begins shipments as FDA approves generic Risperdal: Risperdal is used as a treatment for schizophrenia and some symptoms of autism.
Tuesday, July 01, 2008
Trading Markets (press release), CA -
Jul 01, 2008 (Globes - McClatchy-Tribune Information Services via COMTEX) -- TEVA | Quote | Chart | News | PowerRating -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA | Quote | Chart | ...

Pages: Previous   1   2   3   4   5   6   7   8   9   10   11   ...   Next

Need A Seroquel Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Seroquel Case - Submit Your Information Below

Do you need legal assistance with your Seroquel case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Seroquel Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.